Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis-Reference-Cited by-同舟云学术

Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis

Published:2020-01-04 Issue:2 Volume:115 Page:
ISSN:0300-8428
Container-title:Basic Research in Cardiology
language:en
Short-container-title:Basic Res Cardiol

Author:

Li Jiamin,Xu Chaoqian,Liu Yining,Li Yuanshi,Du Sijia,Zhang Ruijie,Sun Yuehang,Zhang Ronghao,Wang Ying,Xue Hongru,Ni Sha,Asiya Mavlikhanova,Xue Genlong,Li Yanyao,Shi Ling,Li Desheng,Pan Zhenwei,Zhang Yong,Wang Zhiguo,Cai Benzhi,Wang Ning,Yang Baofeng

Funder

National Key R&D Program of China

National Nature Science Foundation of China

Natural Science Foundation of Heilongjiang Province

Basic scientific research Foundation of universities in heilongjiang province

Foundation of Heilongjiang postdoctoral

Heilongjiang Touyan Innovation Team Program

Outstanding Youth Fostering Foundation of Vihan Academician

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s00395-019-0768-4.pdf

Reference46 articles.

1. Agrawal A, Parlee S, Perez-Tilve D, Li P, Pan J, Mroz PA, Kruse Hansen AM, Andersen B, Finan B, Kharitonenkov A, DiMarchi RD (2018) Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity. Mol Metab 13:45–55. https://doi.org/10.1016/j.molmet.2018.05.003

2. Barichello S, Roberts JD, Backx P, Boyle PM, Laksman Z (2018) Personalizing therapy for atrial fibrillation: the role of stem cell and in silico disease models. Cardiovasc Res 114:931–943. https://doi.org/10.1093/cvr/cvy090

3. Bergmark BA, Udell JA, Morrow DA, Cannon CP, Steen DL, Jarolim P, Budaj A, Hamm C, Guo J, Im K, Kuder JF, Braunwald E, Sabatine MS, O'Donoghue ML (2018) Association of fibroblast growth factor 23 with recurrent cardiovascular events in patients after an acute coronary syndrome: a secondary analysis of a randomized clinical trial. JAMA Cardiol 3:473–480. https://doi.org/10.1001/jamacardio.2018.0653

4. Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM (1984) The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69:250–258. https://doi.org/10.1161/01.cir.69.2.250

5. Botker HE, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson SM, Deshwal S, Devaux Y, Di Lisa F, Di Sante M, Efentakis P, Femmino S, Garcia-Dorado D, Giricz Z, Ibanez B, Iliodromitis E, Kaludercic N, Kleinbongard P, Neuhauser M, Ovize M, Pagliaro P, Rahbek-Schmidt M, Ruiz-Meana M, Schluter KD, Schulz R, Skyschally A, Wilder C, Yellon DM, Ferdinandy P, Heusch G (2018) Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res Cardiol 113:39. https://doi.org/10.1007/s00395-018-0696-8

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac-specific deletion of BRG1 ameliorates ventricular arrhythmia in mice with myocardial infarction;Acta Pharmacologica Sinica;2023-10-25

2. CDR1as promotes arrhythmias in myocardial infarction via targeting the NAMPT-NAD+ pathway;Biomedicine & Pharmacotherapy;2023-09

3. Identification of TGF-β-related genes in cardiac hypertrophy and heart failure based on single cell RNA sequencing;Aging;2023-07-26

4. Non-coding RNA and arrhythmias: expression, function, and molecular mechanism;EP Europace;2023-03-07

5. Identification of novel prognostic targets in coronary artery disease and related complications using bioinformatics and next generation sequencing data analysis;2023-02-22